Answer
Rifampicin is not recommended with Emtricitabine/Tenofovir Alafenamide Gilead because its P-gp induction may decrease tenofovir alafenamide plasma concentrations, potentially causing loss of therapeutic effect and development of resistance.
Sources for this answer
- Emtricitabine/Tenofovir Alafenamide Gilead 200 mg/10 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 25Document updated
Sources checked